Clinical Trial Update: Hämeenlinna Metabolic Syndrome Research Program: Surrogate Indicators for Atherosclerosis

View source ↗

Summary

Clinical trial update describing the Hämeenlinna Metabolic Syndrome Research Program, which investigates surrogate indicators for atherosclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease
• Metabolic Syndrome

Snippet

Sponsor: Kanta-Häme Central Hospital | Conditions: Metabolic Syndrome, Coronary Heart Disease | Status: UNKNOWN